--- title: 'Product Expansion Lead at AIOS — Remote, $200k–$400k/yr + 0.15%–0.50% equity at AIOS (YC W20/S21)' canonical: 'https://feeny.ai/job/product-expansion-lead-at-aios-remote-200k-400k-yr-0-15-0-50-equity-aios-yc-w20-hb8fyxsk309b' type: 'job' last_seen: '2026-11-12' --- # Product Expansion Lead at AIOS — Remote, $200k–$400k/yr + 0.15%–0.50% equity at AIOS (YC W20/S21) - **Company:** AIOS (YC W20/S21) - **Location:** Remote - **Employment:** full-time - **Work type:** remote - **Posted:** 2026-11-02 - **Last confirmed live:** 2026-11-12 - **Apply:** https://jobs.ashbyhq.com/aios/257011ce-e0cc-484a-aafb-a7f018810ac7 ## Job description ## About AIOS AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving 200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy exists at the intersection of two strong theses: - The AI doctor that wins will get to escape velocity using GLP-1s, the fastest growing consumer product in history. - The $2T European healthcare market is overlooked by the most talented builders. Our master plan: - Step 0 → $100M/yr by end of 2025: We went from $10M to $100M in 6 months serving the UK GLP-1 market. - Step 1 → $1B ARR by end of 2026: Since April 2025 we've grown from 3k to 200k UK active GLP-1 patients. We’ll continue this growth curve to hit $1B ARR. - Step 2 → $10B ARR by end of 2028: Blitzscale Europe. We’ll be Europe’s largest GLP-1 provider. - Step 3 → $100B/yr by end of 2030: Get regulatory approval across Europe for our Full Autonomous Prescribing (FAP) system. Win contracts at scale with European payers to mass replace human labor. We’ll be the dominant full-stack AI doctor in Europe. - Step 4 → $1T/yr by end of 2035: With one line of code and zero human time, you can use AIOS to treat any patient globally with any medication. In so doing, we’ll become the world’s first trillion-dollar healthcare company. We’re a young, founder-led company. This is still Day 1 and all our work is ahead of us. You can read more about working with us here: [Working at AIOS](https://app.notion.com/p/Working-at-AIOS-5b5c0a584af44de78ac7fb9b2cf8d993?pvs=21) Being the Product Expansion Lead at AIOS We’re building a world-class team. As Product Expansion Lead at AIOS, your fundamental role is to drive new category growth. The rest of the org will stay maniacal about their One Thing (global GLP-1 uptake), while your One Thing will be launching and scaling non-GLP-1 products. We’re currently live with 0 non-GLP-1 products, so this is very much a builder role. If it’s not a GLP-1, you’ll stay the overall DRI in perpetuity: from TOF acquisition through to retention, and everything in-between. You’ll build a lean, killer team under you as the function grows, but to start with it’ll be on you to run the entire motion. You’ll: - Analyze the market to identify which products to launch - Own the growth strategy: Creative, Performance, Funnel work, organic, and lifecycle - Work across Clinical, Product, and Ops teams to make sure protocols, supply chains, and productization are in place for every new category Great performance in this role means average order value (AOV), incremental LTV, and cross-sell rate all improve, starting with our UK business. If you really nail the role, you’ll be a leading candidate for future senior growth roles (VP Growth, CGO). This is a full-time, fully remote role, and you’ll work async in the timezone of your choice — as long as you’re around until midday Pacific Time for calls as needed. You’ll report directly to me, [Richie](https://www.linkedin.com/in/richard-cartwright/) (our CEO). I’m intense, so you’ll also be intense. You’ll work long days and regularly weekends. You’ll also work closely with: - [Dave Lane](https://www.linkedin.com/in/digital-dl/) (Head of Performance) - [Michael McCann](https://www.linkedin.com/in/michael-m-33b79642/) (Head of CRO) ## Key responsibilities - Analysis: Maintain a deep understanding of the consumer health market, and use false-door tests, surveys, competitor analysis, and customer data to build conviction before committing to a launch. - Launches: Take new categories from 0→1. Own the launch plan end-to-end, coordinating Clinical, Product, Ops, and Growth so products go live quickly and cleanly. - Growth: Build the growth strategy for each vertical, from cold acquisition through retention, and everything in-between. You won’t execute every channel yourself, but you’ll remain overall DRI. - Cross-sell: Deftly weave cross-sells into the existing GLP-1 patient journey without adding CVR%-killing friction. - Economics: Own the unit economics of every vertical. Understand CAC, gross margin, attach rate, cross-sell rate, AOV, retention, payback, and incremental LTV. Rapidly iterate based on the numbers. - Retention: Ensure each vertical has a reason to exist beyond the first transaction. Build the product, lifecycle, and customer journey required to drive repeat usage and long-term customer value. - Team: Build a lean, high-performing team as the function scales. Until then, operate as the overall DRI to ensure expansion isn’t blocked. KPIs - AOV: Average order value across the UK business. Baseline: . Target: . - Incremental LTV: LTV added per customer by non-GLP-1 products. Baseline: . Target: . - Cross-sell rate: % of customers buying more than one product line. Baseline: . Target: . Need to have - Category Expansion: You have 3+ years taking an established D2C brand into a category its customers had never bought from it before. - Consumer: You possess deep consumer knowledge, and have worked in international D2C before. You understand the scary pace required at a high-growth consumer start-up. - Growth: You understand customer acquisition well enough to build the growth strategy for a new category, including when to press on the gas and when to block launching. - Commercials: You can evaluate a market quickly, form a strong thesis, and test demand before committing loads of resource. If something’s not working you don’t fall victim to the sunk-cost fallacy — you kill it. - Unit economics: You are fluent in CAC, cross-sell rate, gross margin, AOV, attach rate, retention, payback, and LTV. You lean on your metrics to decide whether a vertical deserves more investment. - Execution: You have led launches that required tight coordination across Product, Ops, Growth, Supply Chain, and other specialist teams without losing pace or ownership. - Builder: You are comfortable being the sole DRI before there is a team. You will fill gaps, mow down blockers, build scrappy solutions, and get the first version live yourself alongside a designer and an engineer. - Pace: You operate with urgency, make high-quality decisions with incomplete information, and are comfortable running multiple workstreams in parallel. ## Nice to have - Regulatory: You’ve brought a regulated consumer product to market and worked through what you could sell, what you could claim, and what evidence you needed to launch. - Evaluation: You’ve weighed building a product in-house against partnering, licensing, or acquiring it. - AI-Native: You use AI as a force-multiplier and can construct agentic workflows yourself. - Talent: You’ve hired and managed a lean team to grow a new category before. You know which first hire to make and what to keep owning yourself. - Founder: You’ve founded something, however small, or joined early enough that getting the first paying customer was partly your problem. - Figure It Out: You’re the person we could drop into an unfamiliar category on Monday. By Friday you’d have spoken to customers, found the people who know the business inside out, and lined up a v1 launch plan. Our cultural standards We aim to make this your life's work. This should be the most challenging, most rewarding role of your life. Accordingly, these are the core cultural standards to which we hold ourselves & our team-members: - Belief in the mission: We will have served 100 million patients by the end of 2030 and we transform the life of most patients who join. We have a lot of work to do. We are obsessed with our patients and are dedicated to the mission. - Unwavering integrity: We are at the frontier, so we often live in ambiguity with no trodden path. When we can't look to others for guidance, we must maintain impeccable ethics and unwavering integrity. - Only the paranoid survive: Bad sh*t is coming. By joining us, you're choosing to sail straight towards the storms with unhesitating conviction. However much we've already done, however far we've already come, it's still Day 1 and all our work is ahead of us. - If we're average we fail: We are only interested in "insanely great", a focus on the quality of our execution that in everyday life would be considered pathological. We have a dedication to excellence and reject incompetence. - Commitment to candor: That which can be destroyed by the truth should be. You get full transparency from the company and the company expects full transparency from you. We never say anything about someone that we wouldn't say to them directly. We give feedback with love and do not need to protect people from fleeting physical sensations. - A maniacal sense of urgency: We execute at an intensity that most people think is impossible. Speed is critical and we need things done yesterday. We all work very hard and in such a competitive world there really is no other way to win. - Enduring frugality: We are frugal. We hate being wasteful and we are anti-luxury. A culture of cheapness keeps us young. We spend our cash wisely & carefully, in a way that would make our grandmas proud. - Bulldozing barriers: The world is malleable and we shape it. We truly believe this and act accordingly. We are relentlessly resourceful and are at the mercy of no-one but ourselves. You'll be shocked how capable you are and how much you can achieve. - Keep your head down: We're boring people doing exciting work. We don't chase short-term status. We ignore short-term dopamine hits and focus on what matters. Outsiders will underestimate us and we revel in that. - The power of focus: We live in a world of power laws and we cannot overestimate the unimportance of practically everything. Know your One Thing, and nail it. "You just build a f\*ing amazing experience. Make each step amazing. Make every decision in the long term interest of the customer. Give the customer massively more value than you take." ## Compensation & Benefits You get paid above market salary and you get early stage equity, so you get really rich if we nail this. - Compensation: $200k–$400k/yr + 0.15%–0.50% equity ## Benefits The stuff below is cool as well. - Healthcare: comprehensive medical insurance (if appropriate). - Remote: our team is fully distributed across the world and functions fully remotely. - Vacation: PTO with a yearly minimum (≥2wks/yr + local national holidays). - Personal development: budget for books, courses, coaching ($1,200/yr). - Personal wellness: budget for gym, health apps ($1,200/yr). - GLP-1s: free membership with a clinic offering GLP-1s. - Health coaching: free biweekly health coaching so you stay healthy. - Work coaching: free biweekly work coaching so you stay sharp + calm. - Equipment: Macbook & work-from-home equipment provided as needed. - What are we missing? We're still early so you get to shape our culture. How to apply - Apply on Ashby ## About AIOS (YC W20/S21) ## Company Overview - **One-liner**: AIOS builds an AI-powered clinical operating system (ClinicOS) that enables consumer healthcare brands to deliver end-to-end direct-to-patient care at near-zero marginal human time. - **Entity Type**: Private (YC W20, seed stage) - **Headquarters**: San Francisco, California, USA - **Founded**: 2021 - **Founders**: Richie Cartwright, Luke Harries ## Core Business - **Primary industries**: Consumer healthcare, telemedicine, health-tech infrastructure - **Target customers**: B2C (patients using Fella Health / Bolt Pharmacy) and B2B (consumer brands using ClinicOS infrastructure) - **Mission statement**: "To build the AI operating system for consumer healthcare — delivering end-to-end care with near-zero marginal human time" and "accelerate the global mass-market adoption of consumer biotech products so every human can live at least 100 healthy years." ## Products & Services - **ClinicOS**: An AI-powered clinical operating system that makes it effortless for consumer brands to offer direct-to-patient healthcare globally. Acts as the company’s core infrastructure platform. - **Fella Health**: A telemedicine clinic for men with obesity, combining GLP-1 medications (semaglutide, tirzepatide) with behavioral coaching and ongoing clinical support. Operates in the US and UK. - **Bolt Pharmacy**: A UK-based pharmacy brand fulfilling prescriptions for the company’s patient network. ## Market Standing - **Valuation / Market Cap**: Not publicly disclosed - **Key Metric**: **> $100M / year revenue**; cashflow positive since June 2023 - **Notable Investors / Partners**: Y Combinator (W20 batch), BrandProject (led seed round in 2021) - **Growth Signals**: Revenue has grown >1000x since August 2021, >200x since August 2022, and >40x since August 2023. Serving >50,000 customers with high NPS. Team of ~100 employees. Ambition to serve 100 million patients by 2035. ## Competitive Advantages - **Vertically integrated AI infrastructure**: By building ClinicOS to power both its own brands (Fella, Bolt) and external partners, AIOS controls the full patient care loop — from acquisition and prescribing to fulfillment and ongoing support. - **Profitability at scale**: Achieved cashflow positive status in June 2023, a rare milestone for a high-growth health-tech startup, indicating unit-economic discipline. - **Early mover in GLP-1 telemedicine**: Focused specifically on the exploding GLP-1 medication market for weight loss, a category with massive and growing demand. ## Strategic Focus - **Immediate priority**: Accelerating the global take-up of GLP-1 medications to solve obesity worldwide. Scaling Fella Health and Bolt Pharmacy while onboarding external brand partners onto ClinicOS. - **Long-term vision**: Extend the ClinicOS infrastructure across many healthcare categories beyond weight loss, aiming to deliver next-generation biotech products at massive scale and become "the world’s first trillion-dollar healthcare company." ## Why Work Here - **Growth trajectory**: Joining a company that has grown revenue >1000x in four years and is profitable offers both impact and job security. - **Mission-driven work**: The team is explicit about getting "the humans out of healthcare" — replacing slow, legacy workflows with software-driven, AI-native care. - **Remote-friendly culture**: Many roles are listed as fully remote (US/UK) with competitive compensation ranges (e.g., Head of Product Growth: $200k–$400k/yr + equity; Head of Product Design: $125k–$250k/yr + equity; UK roles: £85k–£220k). - **YC pedigree**: Founders are Cambridge graduates with prior exit experience (FlowX acquired); the company is part of Y Combinator’s W20 batch. - **Team size**: ~100 employees — small enough for outsized ownership, large enough to have real traction. ## Sources 1. [ycombinator.com](https://www.ycombinator.com/companies/aios) 2. [ycombinator.com/jobs](https://www.ycombinator.com/companies/aios/jobs) 3. [fellahealth.com](https://www.fellahealth.com/) 4. [brandproject.com](https://brandproject.com/brand/aios-medical/) 5. [builtin.com](https://builtin.com/company/fella-delilah) ## Other roles at AIOS (YC W20/S21) - [Creative Strategist at AIOS — Remote, $3k–$8k/mo + 5% of ad spend + bonus](https://feeny.ai/job/creative-strategist-at-aios-remote-3k-8k-mo-5-of-ad-spend-bonus-aios-yc-w20-s21-eqa9ge3m4f9k) - [Senior Security Engineer at AIOS — Remote, $150k–$250k/yr inc equity](https://feeny.ai/job/senior-security-engineer-at-aios-remote-150k-250k-yr-inc-equity-aios-yc-w20-s21-z7spzgqqdgyx) - [Web Designer at AIOS — Remote, $100k-$200k/yr (including equity)](https://feeny.ai/job/web-designer-at-aios-remote-100k-200k-yr-including-equity-aios-yc-w20-s21-europe-fzzf77j9kd5q) — Europe - [Head of Funnel Conversion (CRO) at AIOS — Remote, $200k-$400k/yr + up to 0.3%](https://feeny.ai/job/head-of-funnel-conversion-cro-at-aios-remote-200k-400k-yr-up-to-0-3-aios-yc-w20-rz0rpgzw9kdj) — United States - [Funnel Conversion (CRO) Lead at AIOS — Remote, $150k-$300k/yr (including equity)](https://feeny.ai/job/funnel-conversion-cro-lead-at-aios-remote-150k-300k-yr-including-equity-aios-yc-2yacdj3r2t8n) — United States - [Talent Lead at AIOS- Remote, $100-200k inc equity](https://feeny.ai/job/talent-lead-at-aios-remote-100-200k-inc-equity-aios-yc-w20-s21-remote-akbsee9fa6pq) - [Software Engineer at AIOS — Hybrid, €60k-€120k /yr + equity](https://feeny.ai/job/software-engineer-at-aios-hybrid-60k-120k-yr-equity-aios-yc-w20-s21-kosovo-jh392k3czdws) — Kosovo - [Product Manager - Engagement — Remote, $150k-300k/yr inc equity](https://feeny.ai/job/product-manager-engagement-remote-150k-300k-yr-inc-equity-aios-yc-w20-s21-remote-w2mpvb6etx79) - [AI Engineering Lead at AIOS — Remote, $200-$400k/yr + equity](https://feeny.ai/job/ai-engineering-lead-at-aios-remote-200-400k-yr-equity-aios-yc-w20-s21-remote-f730qkw9fshs) - [Affiliate Lead at AIOS — Remote, $100k-$200/yr inc equity](https://feeny.ai/job/affiliate-lead-at-aios-remote-100k-200-yr-inc-equity-aios-yc-w20-s21-remote-x8twpmfmvk4t)